Effects of calcium antagonists on lipids and atherosclerosis
Authors:
- Alberico L. CatapanoAlberico L. Catapano
- Alberto CorsiniACAlberto Corsini
- Remo FumagalliRFRemo Fumagalli
- Rodolfo PaolettiRPRodolfo Paoletti
- 7 November 1989
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 64 (17) , I129-I134
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Effect of Nisoldipine on Diet‐Induced Atherosclerosis in RabbitsAnnals of the New York Academy of Sciences, 1988
- Antiatherogenic activity of FR34235 (Nilvadipine), a new potent calcium antagonistAtherosclerosis, 1987
- Nifedipine-suppressed atherosclerosis in cholesterol-fed rabbits but not in Watanabe heritable hyperlipidemic rabbitsAtherosclerosis, 1987
- Antiatherogenic properties of calcium antagonistsThe American Journal of Cardiology, 1987
- Preservation of endothelium-dependent vascular relaxation in cholesterol-fed rabbit by treatment with the calcium blocker PN 200110.Circulation Research, 1986
- Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1985
- Calcium antagonists and the suppression of atherosclerosisJournal of Molecular and Cellular Cardiology, 1984
- Mechanism of protection from atherosclerosis by verapamil in the cholesterol-fed rabbitThe American Journal of Cardiology, 1984
- Verapamil suppresses atherosclerosis in cholesterol-fed rabbitsJACC, 1983
- Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.Journal of Clinical Investigation, 1981